Key facts
| Recalling firm | Medtronic, Inc. |
|---|---|
| Manufacturer | Not disclosed in the FDA record. |
| Brand name | Not disclosed in the FDA record. |
| Product description | Azure S DR MRI SureScan, Product number W3DR01 |
| Classification | Class II |
| Recall number | Z-1924-2025 |
| Report date | Not disclosed in the FDA record. |
| Status | Ongoing |
| Reason for recall | Identified devices may experience sudden battery power failure without alarm, power supply power-on-resets, and interruption of therapy. Potential patient harms include insufficient pacing support leading to cardiac arrest, syncope, or hospitalization; or system revision (explant/replacement) leading to infection, hematoma, or temporary impairment. |
What consumers should do
Facilities, clinicians, and consumers holding an affected unit or lot of Azure S DR MRI SureScan, Product number W3DR01 should stop using it for the purpose described in the recall notice and hold remaining stock pending instructions from Medtronic, Inc.. FDA recall records typically direct the recalling firm to notify known accounts directly with a recall letter describing the specific corrective action -- replacement, field correction, refund, or return. Anyone who received the product through a distributor rather than directly from Medtronic, Inc. should confirm with their supplier whether their specific lot or unit is on the affected list, since recall notices are lot- or unit-specific and not every unit of a product line is necessarily included. Questions about a specific unit's status should go to Medtronic, Inc. directly or to the distributor that supplied it; Argus HQ is a public-record aggregator, not the recalling firm, and cannot confirm individual unit status.
What this classification means
A Class II recall is FDA’s middle classification. FDA assigns Class II when use of, or exposure to, the recalled product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote. FDA still requires the recalling firm to notify affected accounts and submit status reports on the correction, though the monitoring intensity is lower than for a Class I recall. FDA's Center for Devices and Radiological Health (for devices) or Center for Drug Evaluation and Research (for drugs) reviews the classification and can require additional corrective action if the initial response is judged insufficient. Because this record is filed as Class II, professionals and consumers handling an affected lot should treat FDA's own classification -- not this page's summary of it -- as the authoritative risk signal. A Class I recall is FDA’s most serious classification. FDA assigns Class I when there is a reasonable probability that use of, or exposure to, the recalled product will cause serious adverse health consequences or death. This classification does not mean harm has already occurred in every case -- it reflects FDA’s assessment of the realistic worst-case risk profile of the defect described in the recall, based on the reason for recall reported by the firm. Class I recalls receive the closest FDA monitoring of the three classes: the recalling firm typically must submit a recall strategy, periodic status reports, and effectiveness checks confirming that the affected lots have actually been removed from distribution or corrected in the field.
Medtronic, Inc.’s FDA history
Argus HQ has recorded 40 total FDA actions tied to Medtronic, Inc.: 0 warning letters, 40 recalls, 0 approval records, and 0 Form 483 inspection citations.
Frequently asked questions
- Who should I contact about this recall?
- Contact Medtronic, Inc. directly, or the distributor/pharmacy that supplied the product, to confirm whether your specific lot or unit is affected. Argus HQ aggregates the public FDA recall record and is not the recalling firm.
- Has Medtronic, Inc. had other FDA recalls or enforcement actions?
- Yes. Argus HQ has recorded 40 total FDA actions tied to Medtronic, Inc., including 40 recalls and 0 warning letters.
- What is the FDA recall number for this event?
- FDA recall number Z-1924-2025.
- What is the current status of this recall?
- Status as recorded by FDA: Ongoing.
Know if this happens again — we'll email you.
Free. No spam, just recall alerts for what you tell us to watch.
Related enforcement actions
Full FDA history for Medtronic, Inc.- Recall: Medtronic Inc — Class II recall: Abre Venous Self-Expanding Stent System, Model numbers AB9G14120090 AB9G1210009… →
- Recall: Medtronic, Inc. — Class II recall: Aurora EV-ICD and Clinical EV-ICD, single chamber, extravascular implantable car… →
- Recall: Medtronic, Inc. — Class II recall: Medtronic CareLink SmartSync Device Manager, Model Number 24967A with the follow… →
- Recall: Medtronic, Inc. — Class II recall: Medtronic CareLink SmartSync Patient Connector, Model Number 24967 with the foll… →
- Recall: Medtronic, Inc. — Class II recall: Medtronic SmartLink Software loaded on SmartSync Patient Connector, Model Number… →
- Recall: Medtronic, Inc. — Class II recall: Medtronic SmartLink software loaded on CareLink SmartSync Device Manager, Model… →
- Recall: Medtronic Inc. — Class II recall: 2090 Programmers with serial number prefixes PKK0 and PKK1: a) 2090, Product… →
- Recall: Medtronic Inc. — Class II recall: COBALT XT HF QUAD CRT-D MRI SureScan, Model Number DTPA2QQ, Implantable Cardiove… →
Compiled by Argus HQ Research from FDA primary sources · Reviewed by Andy Gaber, Founder
Cite this record
Reusing this data in reporting or research? Here’s a ready-made citation.
Argus HQ Research (2025). FDA Class II Recall: Azure S DR MRI SureScan, Product number W3DR01 by Medtronic, Inc.. Digital Empire Holdings LLC. Retrieved from https://argushq.ai/recall/medtronic-z-1924-2025-2025-06-18
"FDA Class II Recall: Azure S DR MRI SureScan, Product number W3DR01 by Medtronic, Inc.." Argus HQ Research, Digital Empire Holdings LLC, 2025, argushq.ai/recall/medtronic-z-1924-2025-2025-06-18.
Argus HQ Research. "FDA Class II Recall: Azure S DR MRI SureScan, Product number W3DR01 by Medtronic, Inc.." Digital Empire Holdings LLC. Accessed August 29, 2026. https://argushq.ai/recall/medtronic-z-1924-2025-2025-06-18.
@misc{argushq_argushq_ai_recall_medtronic_z_1924_2025_2025_06_18_2025,
title = {FDA Class II Recall: Azure S DR MRI SureScan, Product number W3DR01 by Medtronic, Inc.},
author = {{Argus HQ Research}},
year = {2025},
publisher = {Digital Empire Holdings LLC},
url = {https://argushq.ai/recall/medtronic-z-1924-2025-2025-06-18},
note = {Accessed: August 29, 2026}
}Source: FDA.gov — Recalls ↗

